Stimulation of TNF-α release by fungal cell wall polysaccharides

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 60, Issue 11-12, 2005, Pages 921-926

  Majtán, Juraj ^a   Kogan, Grigorij ^a   Kováčová, Elena ^b   Bíliková, Katarína ^a,c   Šimúth, Jozef ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Chitin; Glucan; Tumor Necrosis Factor

Indexed keywords

ASPERGILLUS NIGER; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 29744458603     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2005-11-1216     Document Type: Article

References (46)

1. Abel G. and Czop J. K. (1992), Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β. Int. J. Immunopharmacol. 14, 1363-1373.
2. Adachi Y., Okazaki M., Ohno N., and Yadomae T. (1994), Enhancement of cytokine production of macrophages stimulated with (1→3)-β-D-glucan, Grifolan (GRN) isolated from Grifola frondosa. Biol. Pharm. Bull. 17, 1554-1560.
3. Babincová M., Machová E., and Kogan G. (1999), Carboxymethylated glucan inhibits lipid peroxidation in liposomes. Z. Naturforsch. 54c, 1084-1088.
4. Babineau T. J., Hackford A., Kenler A., Bistrian B., Forse R. A., Fairchild P. G., Heard S., Keroack M., Caushaj P., and Benotti P. (1994), A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch. Surg. 129, 1204-1210.
5. Bartnicki-Garcia S. (1968), Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu. Rev. Microbiol. 22, 87-108.
6. Bohn J. A. and BeMiller J. N. (1995), (1→3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr. Polym. 28, 3-14.
7. Browder W., Williams D., Pretus H., Olivero G., Enrichens F., Mao P., and Franchello A. (1990), Beneficial effect of enhanced macrophage function in trauma patient. Ann. Surg. 211, 605-613.
8. Brown G. D. and Gordon S. (2001), Immune recognition: a new receptor for beta-glucans. Nature 413, 36-37.
9. Čipák L'., Miadoková E., Dingová H., Kogan G., Novotný L., and Rauko P. (2001), Comparative DNA-protectivity and anti-mutagenity studies using the DNA-topology and Ames assays. Toxicol. In Vitro 15, 677-681.
10. Czop J. K. and Austen K. F. (1985), Beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J. Immunol. 134, 2588-2593.
11. Farkaš V. (1979), Biosynthesis of cell walls of fungi. Microbiol. Rev. 43, 117-144.
12. Feng J., Zhao L., and Yu Q. (2004), Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem. Biophys. Res. Commun. 317, 414-420.
13. 3. Immunology 63, 319-324.
14. Havell E. A. (1989), Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143, 2894-2899.
15. Herre J., Gordon S., and Brown G. D. (2004), Dectin-1 and its role in the recognition of β-glucans by macrophages. Mol. Immunol. 40, 869-876.
16. Hirata N., Tsuzuki A., Ohno N., Saita M., Adachi Y., and Yadomae T. (1998), Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1→3)-β-D-glucan preparation, sonifilan. Zentralbl. Bakteriol. 288, 403-413.
17. Khalikova T. A., Zhanaeva S. Ya., Korolenko T. A., Kaledin V. I., and Kogan G. (2005), Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide. Cancer Lett. 223, 77-83.
18. Kogan G. (2000), (1→3,1→6)-β-D-Glucans of yeasts and fungi and their biological activity. In: Studies in Natural Products Chemistry, Vol. 23, Bioactive Natural Products (Part D) (Atta-ur-Rahman, ed.). Elsevier, Amsterdam, pp. 107-152.
19. Kogan G., Alföldi J., and Masler L. (1988), Carbon-13 NMR spectroscopic investigation of two yeast cell wall β-D-glucans. Biopolymers 27, 1055-1063.
20. Kogan G., Masler L., Sandula J., Navarová J., and Trnovec T. (1989), Recent results on the structure and immunomodulating activities of yeast glucan. In: Biomedical and Biotechnological Advances in Industrial Polysaccharides (Crescenzi V., Dea I. C. M., Paoletti S., Stivala S. S., and Sutherland I. W., eds.). Gordon and Breach Science Publishers, New York, pp. 251-258.
21. Kogan G., Šandula J., Korolenko T. A., Falameeva O. V., Poteryaeva O. N., Zhanaeva S. Ya., Levina O. A., Filatova T. G., and Kaledin, V. I. (2002), Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator - yeast carboxymethyl glucan. Int. Immunopharmacol. 2, 775-781.
22. Kogan G., Staško A., Bauerová K., Polovka M., Šoltés L., Brezová V., Navarová J., and Mihalová D. (2005), Antioxidant properties of yeast (1→3)-β-D- glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis. Carbohydr. Polym. 61, 18-28.
23. Machová E., Kogan G., Alföldi J., Šoltés L., and Šandula J. (1995), Enzymatic and ultrasonic depolymerization of carboxymethylated β-1,3-D-glucans derived from Saccharomyces cerevisiae. J. Appl. Polym. Sci. 55, 699-704.
24. Machová E., Kogan G., Šoltés L., Kvapilová K., and Šandula J. (1999), Ultrasonic depolymerization of the chitin-glucan isolated from Aspergillus niger. React. Funct. Polym. 42, 265-271.
25. Maeda Y. Y., Watanabe S. T., Chihara C., and Rokutanda M. (1988), Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses. Cancer Res. 48, 671-675.
26. Ohno N., Asada N., Adachi Y., and Yadomae T. (1995), Enhancement of LPS triggered TNF-α (Tumor Necrosis Factor-α) production by (1→3)-β-D-glucan in mice. Biol. Pharm. Bull. 18, 126-133.
27. Park J. and Rikihisha Y. (1991), Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore and concanavalin A. Infect. Immun. 59, 3418-3423.
28. Peluso G., Petillo O., Ranieri M., Santin M., Ambrosio L., Calabro D., Avalone B., and Balsamo G. (1994), Chitosan-mediated stimulation of macrophage function. Biomaterials 15, 1215-1220.
29. Pretus H. A., Ensley H. E., McNamee R. B., Jones E. L., Browder I. W., and Williams D. L. (1991), Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. J. Pharmacol. Exp. Ther. 257, 500-510.
30. Rice P. J., Kelley J. L., Kogan G., Ensley H. E., Kalbfleisch J. H., Browder I. W., and Williams D. L. (2002), Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans. J. Leukocyte Biol. 72, 140-146.
31. Ross G. D., Cain J. A., Myones B. L., Newman S. L., and Lachmann P. J. (1987), Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement 4, 61-74.
32. Saiki I., Murata J., Nakajima M., Tokura S., and Azuma I. (1990), Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res. 50, 3631-3637.
33. Sakagami Y., Mizoguchi Y., Shin T., Seki S., Kobayashi K., Morisawa S., and Yamamoto S. (1988), Effects of an anti-tumor polysaccharide, schizophyllan, on interferon-gamma and interleukin 2 production by peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 155, 650-655.
34. Sherwood E. R., Williams D. L., and DiLuzio N. R. (1986), Glucan stimulates production of antitumor cytolytic/cytostatic factor(s) by macrophages. J. Biol. Response Modif. 5, 504-526.
35. Sherwood E. R., Williams D. L., McNamee R. B., Jones E. L., Browder I. W., and DiLuzio N. R. (1987), In vitro tumoricidal activity of resting and glucan-activated Kupffer cells. J. Leukocyte Biol. 42, 69-75.
36. Slameňová D., Lábaj J., Križková L., Kogan G., Šandula, J., Bresgen N., and Eckl P. (2003), Protective effects of fungal (1→3)-β-D-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Lett. 198, 153-160.
37. Suzuki K., Mikami T., Okawa Y., Tokoro A., and Suzuki, M. (1987), Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose. Carbohydr. Res. 151, 403-408.
38. Tabata K., Ito W., Kojima T., Kawabata S., and Misaki, A. (1981), Ultrasonic degradation of schizophyllan, an antitumor polysaccharide produced by Schizophyllum commune Fries. Carbohydr. Res. 89, 121-135.
39. Thornton B. P., Vetvicka V., Pitman M., Goldman R. C., and Ross G. D. (1996), Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156, 1235-1246.
40. Tokunaka K., Ohno N., Adachi Y., Tanaka S., Tamura H., and Yadomae T. (2000), Immunopharmacological and immunotoxicological activities of a water-soluble (1→3)-β-D-glucan, CSBG from Candida spp. Int. J. Immunopharmacol. 22, 383-394.
41. Vetvicka V., Thornton B. P., and Ross G. D. (1996), Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98, 50-57.
42. Watanabe N. and Niitsu Y. (1991), Antitumor effect of tumor necrosis factor. Biotherapy 5, 1634-1643.
43. Williams D. L. (1997), Overview of (1→3)-β-D-glucan immunobiology. Mediators Inflamm. 6, 247-250.
44. Williams J. D., Topley N., Alobaidi H. M., and Harber M. J. (1986), Activation of human polymorphonuclear leukocytes by particular zymosan is related to both its major carbohydrate components: glucan and mannan. Immunology 58, 117-124.
45. Williams D. L., Mueller A., and Browder W. (1996), Glucan-based macrophage stimulators. A review of their anti-infective potential. Clin. Immunother. 5, 392-399.
46. Zimmerman J. W., Lindermuth J., Fish P. A., Palace G. P., Stevenson T. T., and DeMong D. E. (1998), A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273, 22014-22020.